Compared with mutational profiling routinely analyzed using tumor samples, TP53, SMAD4, APC, AKT1, GNAS, IDH1, IDH2, and PDGFRA mutations were the additional mutations identified by this cfDNA assay. The gene discussed is AKT1; the disease is neoplasm.